Observations on improving COVID-19 vaccination responses in kidney transplant recipients: heterologous vaccination and immunosuppression modulation.

Kidney Int · 2022 · PMC8651481 · PMID 34890687

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Seroconversion rates and antibody titers induced by heterologous vaccination were at least equal to mRNA-exclusive vaccination in immunocompromised transplant recipients; although they trended higher in the heterologous group, this did not reach statistical significance because of the small cohort size.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.